Modulation of EGFR Activity by Molecularly Imprinted Polymer Nanoparticles Targeting Intracellular Epitopes
Stanislav S Piletsky1, Ekaterina Baidyuk2,3, Elena V Piletska4
1Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, White City Campus, London W12 0BZ, United Kingdom.
Molecularly imprinted polymer nanoparticles (nanoMIPs) targeting intracellular epidermal growth factor receptor (EGFR) domains show promise for cancer therapy. These nanoMIPs sequester EGFR, reducing its function and impacting cancer cell viability.
Area of Science:
- Biotechnology
- Nanomedicine
- Cancer Research
Background:
- Molecularly imprinted polymer nanoparticles (nanoMIPs) are emerging as alternatives to antibodies for diagnostics and therapeutics.
- Key questions exist regarding the suitability of intracellular targets for nanoMIPs and their potential for modulating protein function.
Purpose of the Study:
- To investigate the efficacy of nanoMIPs targeting intracellular epitopes of the epidermal growth factor receptor (EGFR).
- To determine if targeting specific EGFR epitopes can modulate protein function and impact cancer cell behavior.
Main Methods:
- Synthesized nanoMIPs using extracellular and intracellular EGFR epitopes as templates.
- Treated cancer cells with varying EGFR expression levels using the developed nanoMIPs.
- Assessed EGFR localization, autophosphorylation, and cell viability.
Main Results:
- NanoMIPs targeting intracellular EGFR kinase and extracellular ligand-binding domains induced EGFR sequestration into cellular foci.
- Significant reduction in EGFR autophosphorylation was observed.
- NanoMIP treatment demonstrated effects on cancer cell viability.
Conclusions:
- Intracellular domain-targeting nanoMIPs are effective in modulating EGFR function.
- NanoMIPs targeting intracellular EGFR epitopes represent a potential novel therapeutic strategy for cancer treatment.
More Related Videos
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
09:09Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020
Related Concept Videos
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Targeted Cancer Therapies
There are several types of targeted therapies against...
